What are the causes of elevated trimethylamine N‑oxide (TMAO) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated TMAO Levels

Elevated TMAO levels result from three primary mechanisms: dietary intake of TMAO precursors (L-carnitine and phosphatidylcholine from red meat, eggs, and full-fat dairy), direct consumption of TMAO-rich foods (certain fish and seafood), and reduced renal clearance in kidney disease. 1

Primary Dietary Sources

Animal-Based Foods Rich in TMAO Precursors

  • Red meat and processed meats contain high levels of L-carnitine and phosphatidylcholine, which gut microbes convert to trimethylamine (TMA), subsequently oxidized by hepatic flavin-containing monooxygenases (FMOs) to TMAO 1
  • Eggs (particularly yolk) and full-fat dairy products are abundant sources of phosphatidylcholine that undergo microbial conversion to TMA and then TMAO 2
  • Proteolytic fermentation by gut bacteria of these animal proteins produces TMA as an intermediate metabolite 1

Direct TMAO-Containing Foods

  • Fish and seafood naturally contain TMAO, with content varying widely by species and depth of water where caught 2, 3
  • Fish sticks, cod, and salmon consumption can lead to significant transient increases in circulating TMAO levels 3
  • TMAO accumulates in fish muscle as protection against pressure and cold in deep-sea environments 3
  • Shrimp and tuna also contain variable amounts of preformed TMAO 3

Supplementation-Related Sources

  • Betaine supplementation may be converted by gut microflora into methylamine-N-oxide and subsequently metabolized into TMAO, potentially having negative long-term cardiovascular impact 4, 5
  • Choline supplementation can be converted to TMAO by gut bacteria, with an upper limit of 3.5 g/day recommended to minimize this risk 4, 6

Metabolic and Physiological Factors

Gut Microbiome Composition

  • Specific gut bacterial species convert dietary choline and L-carnitine into TMA through microbial choline TMA-lyase enzymes 7
  • Uremic dysbiosis in chronic kidney disease results in overgrowth of microorganisms that increase TMA production 8, 2
  • The profile of gut microbiota varies according to host genetics, dietary patterns, disease state, and environmental factors 2

Hepatic Metabolism

  • Hepatic flavin-containing monooxygenases (FMOs), particularly FMO3, oxidize gut-derived TMA to TMAO 1
  • Cruciferous vegetables can inhibit FMO3 activity, potentially reducing TMAO production from precursors 1, 4
  • Elevated hepatic enzymatic activity in uremic states increases TMAO generation 2

Renal Function Impairment

  • Reduced kidney function leads to decreased TMAO excretion, causing accumulation in circulation 8, 2
  • TMAO is normally efficiently excreted by the kidneys, and plasma TMAO concentration is significantly increased in chronic kidney disease patients 1, 8
  • TMAO levels in humans are often confounded by reduced kidney function rather than solely reflecting dietary intake 1

Important Clinical Caveats

The Fish Paradox

  • Despite fish being rich in TMAO and its precursors, epidemiological findings consistently link fatty fish consumption with beneficial cardiometabolic outcomes 1, 4
  • The American Heart Association recommends consuming nonfried seafood 1-2 times per week for cardiovascular benefits, acknowledging that concerns about TMAO from fish are not supported by evidence showing cardiovascular benefits from seafood 4
  • Circulating TMAO levels return to baseline within 1 day after fish consumption in individuals with normal renal function 3

Modifiable Risk Factors

  • Limiting red meat and processed meats reduces not only TMAO but also other detrimental metabolites including ammonia, p-cresol, and hydrogen sulfide 4
  • Plant-based diets show promise for reducing gut-derived TMAO production by decreasing intake of animal-based precursors 9
  • Selection of low TMAO content fish is prudent for subjects with elevated TMAO, cardiovascular disease, or impaired renal function 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Managing Cardiac Risks Associated with TMAO

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Betaine Supplementation and Cardiovascular Health

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Val158Met COMT Polymorphism and Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.